> [Original Message] > From: CDER MEDWATCH LISTSERV <[EMAIL PROTECTED]> > To: <[EMAIL PROTECTED]> > Date: 2/16/2007 6:35:45 PM > Subject: FDA - MedWatch - Unsafe, Misrepresented Drugs Purchased Over the Internet: Ambien (zolpidem tartrate), Xanax (alprazolam), Lexapro ( escitalopram oxalate), Ativan (lorazepam) > > MedWatch - The FDA Safety Information and Adverse Event Reporting Program > > FDA informed consumers and healthcare professionals regarding the > possible dangers of buying prescription medications online. Individuals > who ordered Ambien, Xanax, Lexapro, and Ativan over the internet > received a product that contained haloperidol, a powerful anti-psychotic > drug. Several consumers experienced difficulty in breathing, muscle > spasms and muscle stiffness after ingesting the suspect product and had > to seek emergency medical treatment. Haloperiodol can cause muscle > stiffness, spasms, agitation and sedation. Taking medication that > contains an active ingredient other than what is prescribed by qualified > healthcare professionals is generally unsafe. FDA urges consumers to > review the FDA website for additional information prior to making > purchases of medications over the internet > (http://www.fda.gov/buyonline/). > > Read the complete MedWatch 2007 Safety summary, including links to the > FDA Press Release regarding this issue at: > > http://www.fda.gov/medwatch/safety/2007/safety07.htm#internet > > _________________________________________________________________ > > To ensure delivery of these timely alerts to your in-box and prevent rejection of the notice by a spam filter, please add our MedWatch address, [EMAIL PROTECTED], to your address book. > > Thank you for using FDA MedWatch as a trusted source for timely safety information on drugs, devices and diagnostics regulated by the U.S. Food and Drug Administration. If you find this e-mail notification helpful, please consider telling colleagues and friends about MedWatch and this e-mail notification process. They can learn more and subscribe to the e-list at http://www.fda.gov/medwatch. > > To send a comment or question to the MedWatch program: http://www.fda.gov/medwatch/feedback.htm > > To unsubscribe from this listserve: > https://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1
